カテゴリ： 世界, 医療/バイオ, Market Monitor Global

無血清幹細胞培地のグローバル市場展望 2023年-2029年：DMSOあり、DMSOフリー

■ 英語タイトル：Serum Free Stem Cell Medium Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY7967）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY7967
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：111
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[無血清幹細胞培地のグローバル市場展望 2023年-2029年：DMSOあり、DMSOフリー]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の無血清幹細胞培地市場規模と予測を収録しています。・世界の無血清幹細胞培地市場：売上、2018年-2023年、2024年-2029年
・世界の無血清幹細胞培地市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の無血清幹細胞培地市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「DMSOあり」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

無血清幹細胞培地のグローバル主要企業は、Thermo Fisher Scientific、 Athena Environmental Sciences、 Pan Biotech、 Sigma-Aldrich、 CellGenix、 GE Healthcare、 Merck、 Zenoaq、 STEMCELL、 BioLifeSolutions、 Bio-Techne、 Lonza、 Nippon Genetics、 HiMedia、 PromoCell、 Biological Industries、 Irvine Scientific、 Wolcaviなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、無血清幹細胞培地のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の無血清幹細胞培地市場：タイプ別、2018年-2023年、2024年-2029年
世界の無血清幹細胞培地市場：タイプ別市場シェア、2022年
・DMSOあり、DMSOフリー

世界の無血清幹細胞培地市場：用途別、2018年-2023年、2024年-2029年
世界の無血清幹細胞培地市場：用途別市場シェア、2022年
・バイオ医薬品産業、臨床研究機関、研究センター、その他

世界の無血清幹細胞培地市場：地域・国別、2018年-2023年、2024年-2029年
世界の無血清幹細胞培地市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における無血清幹細胞培地のグローバル売上、2018年-2023年
・主要企業における無血清幹細胞培地のグローバル売上シェア、2022年
・主要企業における無血清幹細胞培地のグローバル販売量、2018年-2023年
・主要企業における無血清幹細胞培地のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Thermo Fisher Scientific、 Athena Environmental Sciences、 Pan Biotech、 Sigma-Aldrich、 CellGenix、 GE Healthcare、 Merck、 Zenoaq、 STEMCELL、 BioLifeSolutions、 Bio-Techne、 Lonza、 Nippon Genetics、 HiMedia、 PromoCell、 Biological Industries、 Irvine Scientific、 Wolcavi

*************************************************************

・調査・分析レポートの概要
無血清幹細胞培地市場の定義
市場セグメント
世界の無血清幹細胞培地市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の無血清幹細胞培地市場規模
世界の無血清幹細胞培地市場規模：2022年 VS 2029年
世界の無血清幹細胞培地市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの無血清幹細胞培地の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の無血清幹細胞培地製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：DMSOあり、DMSOフリー
無血清幹細胞培地のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：バイオ医薬品産業、臨床研究機関、研究センター、その他
無血清幹細胞培地の用途別グローバル売上・予測

・地域別市場分析
地域別無血清幹細胞培地市場規模 2022年と2029年
地域別無血清幹細胞培地売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Thermo Fisher Scientific、 Athena Environmental Sciences、 Pan Biotech、 Sigma-Aldrich、 CellGenix、 GE Healthcare、 Merck、 Zenoaq、 STEMCELL、 BioLifeSolutions、 Bio-Techne、 Lonza、 Nippon Genetics、 HiMedia、 PromoCell、 Biological Industries、 Irvine Scientific、 Wolcavi
...

Serum-free media and reagents are widely used to culture mammalian and invertebrate cells to prepare monoclonal antibodies, viral antigens, and recombinant proteins. Most serum-free media contain transferrin, which transports ions into cells, and insulin, which regulates glucose uptake, as well as some proteins and albumin, fibrin, fetuin, etc., which play various roles in cell culture. functions, such as providing the matrix required for cell adhesion, resisting bioreactor shear stress, and serving as a carrier for lipids and other growth differentiation factors.
This report aims to provide a comprehensive presentation of the global market for Serum Free Stem Cell Medium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Serum Free Stem Cell Medium. This report contains market size and forecasts of Serum Free Stem Cell Medium in global, including the following market information:
Global Serum Free Stem Cell Medium Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Serum Free Stem Cell Medium Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Serum Free Stem Cell Medium companies in 2022 (%)
The global Serum Free Stem Cell Medium market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
With DMSO Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Serum Free Stem Cell Medium include Thermo Fisher Scientific, Athena Environmental Sciences, Pan Biotech, Sigma-Aldrich, CellGenix, GE Healthcare, Merck, Zenoaq and STEMCELL, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Serum Free Stem Cell Medium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Serum Free Stem Cell Medium Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Serum Free Stem Cell Medium Market Segment Percentages, by Type, 2022 (%)
With DMSO
DMSO-Free
Global Serum Free Stem Cell Medium Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Serum Free Stem Cell Medium Market Segment Percentages, by Application, 2022 (%)
Biopharma Industry
Clinical Research Organizations
Research Centers
Others
Global Serum Free Stem Cell Medium Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Serum Free Stem Cell Medium Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Serum Free Stem Cell Medium revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Serum Free Stem Cell Medium revenues share in global market, 2022 (%)
Key companies Serum Free Stem Cell Medium sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Serum Free Stem Cell Medium sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Athena Environmental Sciences
Pan Biotech
Sigma-Aldrich
CellGenix
GE Healthcare
Merck
Zenoaq
STEMCELL
BioLifeSolutions
Bio-Techne
Lonza
Nippon Genetics
HiMedia
PromoCell
Biological Industries
Irvine Scientific
Wolcavi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Serum Free Stem Cell Medium, market overview.
Chapter 2: Global Serum Free Stem Cell Medium market size in revenue and volume.
Chapter 3: Detailed analysis of Serum Free Stem Cell Medium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Serum Free Stem Cell Medium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Serum Free Stem Cell Medium capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Serum Free Stem Cell Medium Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Serum Free Stem Cell Medium Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Serum Free Stem Cell Medium Overall Market Size
2.1 Global Serum Free Stem Cell Medium Market Size: 2022 VS 2029
2.2 Global Serum Free Stem Cell Medium Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Serum Free Stem Cell Medium Sales: 2018-2029
3 Company Landscape
3.1 Top Serum Free Stem Cell Medium Players in Global Market
3.2 Top Global Serum Free Stem Cell Medium Companies Ranked by Revenue
3.3 Global Serum Free Stem Cell Medium Revenue by Companies
3.4 Global Serum Free Stem Cell Medium Sales by Companies
3.5 Global Serum Free Stem Cell Medium Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Serum Free Stem Cell Medium Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Serum Free Stem Cell Medium Product Type
3.8 Tier 1, Tier 2 and Tier 3 Serum Free Stem Cell Medium Players in Global Market
3.8.1 List of Global Tier 1 Serum Free Stem Cell Medium Companies
3.8.2 List of Global Tier 2 and Tier 3 Serum Free Stem Cell Medium Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Serum Free Stem Cell Medium Market Size Markets, 2022 & 2029
4.1.2 With DMSO
4.1.3 DMSO-Free
4.2 By Type – Global Serum Free Stem Cell Medium Revenue & Forecasts
4.2.1 By Type – Global Serum Free Stem Cell Medium Revenue, 2018-2023
4.2.2 By Type – Global Serum Free Stem Cell Medium Revenue, 2024-2029
4.2.3 By Type – Global Serum Free Stem Cell Medium Revenue Market Share, 2018-2029
4.3 By Type – Global Serum Free Stem Cell Medium Sales & Forecasts
4.3.1 By Type – Global Serum Free Stem Cell Medium Sales, 2018-2023
4.3.2 By Type – Global Serum Free Stem Cell Medium Sales, 2024-2029
4.3.3 By Type – Global Serum Free Stem Cell Medium Sales Market Share, 2018-2029
4.4 By Type – Global Serum Free Stem Cell Medium Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Serum Free Stem Cell Medium Market Size, 2022 & 2029
5.1.2 Biopharma Industry
5.1.3 Clinical Research Organizations
5.1.4 Research Centers
5.1.5 Others
5.2 By Application – Global Serum Free Stem Cell Medium Revenue & Forecasts
5.2.1 By Application – Global Serum Free Stem Cell Medium Revenue, 2018-2023
5.2.2 By Application – Global Serum Free Stem Cell Medium Revenue, 2024-2029
5.2.3 By Application – Global Serum Free Stem Cell Medium Revenue Market Share, 2018-2029
5.3 By Application – Global Serum Free Stem Cell Medium Sales & Forecasts
5.3.1 By Application – Global Serum Free Stem Cell Medium Sales, 2018-2023
5.3.2 By Application – Global Serum Free Stem Cell Medium Sales, 2024-2029
5.3.3 By Application – Global Serum Free Stem Cell Medium Sales Market Share, 2018-2029
5.4 By Application – Global Serum Free Stem Cell Medium Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Serum Free Stem Cell Medium Market Size, 2022 & 2029
6.2 By Region – Global Serum Free Stem Cell Medium Revenue & Forecasts
6.2.1 By Region – Global Serum Free Stem Cell Medium Revenue, 2018-2023
6.2.2 By Region – Global Serum Free Stem Cell Medium Revenue, 2024-2029
6.2.3 By Region – Global Serum Free Stem Cell Medium Revenue Market Share, 2018-2029
6.3 By Region – Global Serum Free Stem Cell Medium Sales & Forecasts
6.3.1 By Region – Global Serum Free Stem Cell Medium Sales, 2018-2023
6.3.2 By Region – Global Serum Free Stem Cell Medium Sales, 2024-2029
6.3.3 By Region – Global Serum Free Stem Cell Medium Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Serum Free Stem Cell Medium Revenue, 2018-2029
6.4.2 By Country – North America Serum Free Stem Cell Medium Sales, 2018-2029
6.4.3 US Serum Free Stem Cell Medium Market Size, 2018-2029
6.4.4 Canada Serum Free Stem Cell Medium Market Size, 2018-2029
6.4.5 Mexico Serum Free Stem Cell Medium Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Serum Free Stem Cell Medium Revenue, 2018-2029
6.5.2 By Country – Europe Serum Free Stem Cell Medium Sales, 2018-2029
6.5.3 Germany Serum Free Stem Cell Medium Market Size, 2018-2029
6.5.4 France Serum Free Stem Cell Medium Market Size, 2018-2029
6.5.5 U.K. Serum Free Stem Cell Medium Market Size, 2018-2029
6.5.6 Italy Serum Free Stem Cell Medium Market Size, 2018-2029
6.5.7 Russia Serum Free Stem Cell Medium Market Size, 2018-2029
6.5.8 Nordic Countries Serum Free Stem Cell Medium Market Size, 2018-2029
6.5.9 Benelux Serum Free Stem Cell Medium Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Serum Free Stem Cell Medium Revenue, 2018-2029
6.6.2 By Region – Asia Serum Free Stem Cell Medium Sales, 2018-2029
6.6.3 China Serum Free Stem Cell Medium Market Size, 2018-2029
6.6.4 Japan Serum Free Stem Cell Medium Market Size, 2018-2029
6.6.5 South Korea Serum Free Stem Cell Medium Market Size, 2018-2029
6.6.6 Southeast Asia Serum Free Stem Cell Medium Market Size, 2018-2029
6.6.7 India Serum Free Stem Cell Medium Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Serum Free Stem Cell Medium Revenue, 2018-2029
6.7.2 By Country – South America Serum Free Stem Cell Medium Sales, 2018-2029
6.7.3 Brazil Serum Free Stem Cell Medium Market Size, 2018-2029
6.7.4 Argentina Serum Free Stem Cell Medium Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Serum Free Stem Cell Medium Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Serum Free Stem Cell Medium Sales, 2018-2029
6.8.3 Turkey Serum Free Stem Cell Medium Market Size, 2018-2029
6.8.4 Israel Serum Free Stem Cell Medium Market Size, 2018-2029
6.8.5 Saudi Arabia Serum Free Stem Cell Medium Market Size, 2018-2029
6.8.6 UAE Serum Free Stem Cell Medium Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Serum Free Stem Cell Medium Major Product Offerings
7.1.4 Thermo Fisher Scientific Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.1.5 Thermo Fisher Scientific Key News & Latest Developments
7.2 Athena Environmental Sciences
7.2.1 Athena Environmental Sciences Company Summary
7.2.2 Athena Environmental Sciences Business Overview
7.2.3 Athena Environmental Sciences Serum Free Stem Cell Medium Major Product Offerings
7.2.4 Athena Environmental Sciences Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.2.5 Athena Environmental Sciences Key News & Latest Developments
7.3 Pan Biotech
7.3.1 Pan Biotech Company Summary
7.3.2 Pan Biotech Business Overview
7.3.3 Pan Biotech Serum Free Stem Cell Medium Major Product Offerings
7.3.4 Pan Biotech Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.3.5 Pan Biotech Key News & Latest Developments
7.4 Sigma-Aldrich
7.4.1 Sigma-Aldrich Company Summary
7.4.2 Sigma-Aldrich Business Overview
7.4.3 Sigma-Aldrich Serum Free Stem Cell Medium Major Product Offerings
7.4.4 Sigma-Aldrich Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.4.5 Sigma-Aldrich Key News & Latest Developments
7.5 CellGenix
7.5.1 CellGenix Company Summary
7.5.2 CellGenix Business Overview
7.5.3 CellGenix Serum Free Stem Cell Medium Major Product Offerings
7.5.4 CellGenix Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.5.5 CellGenix Key News & Latest Developments
7.6 GE Healthcare
7.6.1 GE Healthcare Company Summary
7.6.2 GE Healthcare Business Overview
7.6.3 GE Healthcare Serum Free Stem Cell Medium Major Product Offerings
7.6.4 GE Healthcare Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.6.5 GE Healthcare Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Serum Free Stem Cell Medium Major Product Offerings
7.7.4 Merck Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Zenoaq
7.8.1 Zenoaq Company Summary
7.8.2 Zenoaq Business Overview
7.8.3 Zenoaq Serum Free Stem Cell Medium Major Product Offerings
7.8.4 Zenoaq Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.8.5 Zenoaq Key News & Latest Developments
7.9 STEMCELL
7.9.1 STEMCELL Company Summary
7.9.2 STEMCELL Business Overview
7.9.3 STEMCELL Serum Free Stem Cell Medium Major Product Offerings
7.9.4 STEMCELL Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.9.5 STEMCELL Key News & Latest Developments
7.10 BioLifeSolutions
7.10.1 BioLifeSolutions Company Summary
7.10.2 BioLifeSolutions Business Overview
7.10.3 BioLifeSolutions Serum Free Stem Cell Medium Major Product Offerings
7.10.4 BioLifeSolutions Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.10.5 BioLifeSolutions Key News & Latest Developments
7.11 Bio-Techne
7.11.1 Bio-Techne Company Summary
7.11.2 Bio-Techne Serum Free Stem Cell Medium Business Overview
7.11.3 Bio-Techne Serum Free Stem Cell Medium Major Product Offerings
7.11.4 Bio-Techne Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.11.5 Bio-Techne Key News & Latest Developments
7.12 Lonza
7.12.1 Lonza Company Summary
7.12.2 Lonza Serum Free Stem Cell Medium Business Overview
7.12.3 Lonza Serum Free Stem Cell Medium Major Product Offerings
7.12.4 Lonza Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.12.5 Lonza Key News & Latest Developments
7.13 Nippon Genetics
7.13.1 Nippon Genetics Company Summary
7.13.2 Nippon Genetics Serum Free Stem Cell Medium Business Overview
7.13.3 Nippon Genetics Serum Free Stem Cell Medium Major Product Offerings
7.13.4 Nippon Genetics Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.13.5 Nippon Genetics Key News & Latest Developments
7.14 HiMedia
7.14.1 HiMedia Company Summary
7.14.2 HiMedia Business Overview
7.14.3 HiMedia Serum Free Stem Cell Medium Major Product Offerings
7.14.4 HiMedia Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.14.5 HiMedia Key News & Latest Developments
7.15 PromoCell
7.15.1 PromoCell Company Summary
7.15.2 PromoCell Business Overview
7.15.3 PromoCell Serum Free Stem Cell Medium Major Product Offerings
7.15.4 PromoCell Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.15.5 PromoCell Key News & Latest Developments
7.16 Biological Industries
7.16.1 Biological Industries Company Summary
7.16.2 Biological Industries Business Overview
7.16.3 Biological Industries Serum Free Stem Cell Medium Major Product Offerings
7.16.4 Biological Industries Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.16.5 Biological Industries Key News & Latest Developments
7.17 Irvine Scientific
7.17.1 Irvine Scientific Company Summary
7.17.2 Irvine Scientific Business Overview
7.17.3 Irvine Scientific Serum Free Stem Cell Medium Major Product Offerings
7.17.4 Irvine Scientific Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.17.5 Irvine Scientific Key News & Latest Developments
7.18 Wolcavi
7.18.1 Wolcavi Company Summary
7.18.2 Wolcavi Business Overview
7.18.3 Wolcavi Serum Free Stem Cell Medium Major Product Offerings
7.18.4 Wolcavi Serum Free Stem Cell Medium Sales and Revenue in Global (2018-2023)
7.18.5 Wolcavi Key News & Latest Developments
8 Global Serum Free Stem Cell Medium Production Capacity, Analysis
8.1 Global Serum Free Stem Cell Medium Production Capacity, 2018-2029
8.2 Serum Free Stem Cell Medium Production Capacity of Key Manufacturers in Global Market
8.3 Global Serum Free Stem Cell Medium Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Serum Free Stem Cell Medium Supply Chain Analysis
10.1 Serum Free Stem Cell Medium Industry Value Chain
10.2 Serum Free Stem Cell Medium Upstream Market
10.3 Serum Free Stem Cell Medium Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Serum Free Stem Cell Medium Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 無血清凍結培地のグローバル市場展望 2023年-2029年：DMSOあり、DMSOフリー
  • 細胞用無血清培地のグローバル市場展望 2023年-2029年：DMSOあり、DMSOなし
  • 無血清細胞培養培地のグローバル市場展望 2023年-2029年：液体、乾燥粉末
  • 間葉系幹細胞（MSC）療法のグローバル市場展望 2023年-2029年：静脈内（IV）、経鼻（IN）、関節内（IA）、その他
  • 創傷治癒用幹細胞治療のグローバル市場展望 2023年-2029年：間葉系幹細胞、脂肪由来幹細胞、骨髄由来幹細胞、胚性幹細胞、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY7967 )"無血清幹細胞培地のグローバル市場展望 2023年-2029年：DMSOあり、DMSOフリー" (英文：Serum Free Stem Cell Medium Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。